Skip to main content
Polaris Group logo

Polaris Group — Investor Relations & Filings

Ticker · 6550 ISIN · KYG7171A1085 TW Manufacturing
Open in API
Filings indexed 49 across all filing types
Latest filing 2026-05-12 Share Issue/Capital Cha…
Country TW Taiwan
Listing TW 6550

About Polaris Group

https://www.polarispharma.com

Polaris Group is a biotechnology company dedicated to the development of novel anti-cancer therapies and the provision of Contract Development and Manufacturing Organization (CDMO) services. The company’s core research focuses on ADI-PEG 20 (pegargiminase), a biological agent that utilizes metabolic therapy to target arginine-dependent cancers. This candidate is currently in late-stage clinical development for multiple indications, including mesothelioma, soft tissue sarcoma, and hepatocellular carcinoma. Polaris Group maintains a vertically integrated business model, encompassing drug design, clinical trial management, and internal manufacturing capabilities. It operates cGMP-compliant facilities and has expanded its CDMO portfolio to include complex injectables and synthetic peptides. The company aims to deliver innovative treatment options by leveraging its proprietary technology and global clinical partnerships.

Recent filings

Filing Released Lang Actions
公告本公司董事會決議辦理現金增資私募普通股定價相關事宜
Share Issue/Capital Change Classification · 90% confidence The document is a public disclosure by the company’s finance manager detailing the board resolution to conduct a cash capital increase via private placement of ordinary shares. It provides full details on share count, pricing methodology, lock-up conditions, and use of proceeds. This is clearly an announcement of a new share issue / capital change, fitting the "Share Issue/Capital Change" category (SHA).
2026-05-12 Chinese
公告本公司背書保證達「公開發行公司資金貸與及背書保證處理 準則」第二十五條第一項第三款之公告標準
Regulatory Filings Classification · 85% confidence The document is a mandatory disclosure on the Taiwan Market Observation Post System regarding the company’s endorsements/guarantees under the “公開發行公司資金貸與及背書保證處理準則.” It is not a financial report, earnings release, share issue, or management change but rather a compliance/regulatory announcement required by the exchange. It therefore falls under the general Regulatory Filings category.
2026-05-12 Chinese
本公司民國115年度第一季合併財務報告業經董事會決議通過
Interim / Quarterly Report Classification · 90% confidence The document is a regulatory filing from the company on the public information observatory, reporting actual consolidated Q1 (115/01/01–115/03/31) financial data (revenue, profit/losses, EPS, assets, liabilities, equity). It contains substantive numbers rather than just a link or statement of publication, matching the definition of an Interim / Quarterly Report (IR) for a period shorter than a full year. Q1 2026
2026-05-12 Chinese
公告本公司115年第一季合併財務報告董事會召開日期
Regulatory Filings
2026-05-04 Chinese
114年年報及股東會資料 — 2025_6550_20251226F05.pdf
Share Issue/Capital Change Classification · 88% confidence The document is the formal minutes (議事錄) of an extraordinary shareholders meeting of Polaris Group held on 26 December, where the sole agenda was to approve a private placement of up to 150 million new common shares to raise operating funds and repay bank debt. It includes detailed capital increase terms, subscriber criteria, pricing methodology, board authorizations, and actual voting results. This is clearly a notice of a share issuance and capital structure change, matching the definition for Share Issue/Capital Change (Code: SHA).
2026-04-24 Chinese
114年年報及股東會資料 — 2025_6550_20251226FE1.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice of an extraordinary general meeting of shareholders, including information on the meeting agenda, proxy forms, voting methods, and solicitation details. This matches the definition of ‘Proxy Solicitation & Information Statement (PSI)’—materials sent to shareholders to provide information and request votes for meetings. It is not a full annual report, regulatory filing, or vote result announcement.
2026-04-24 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.